Stockscreener 앱 받기
130.55
0.86%
1.11
시장 영업 전:
130.00
-0.55
-0.42%
전일 마감가:
$129.44
열려 있는:
$129.035
하루 거래량:
1.66M
Relative Volume:
1.00
시가총액:
$19.13B
수익:
$9.82B
순이익/손실:
$1.48B
주가수익비율:
12.89
EPS:
10.13
순현금흐름:
$2.30B
1주 성능:
+6.00%
1개월 성능:
+10.07%
6개월 성능:
-16.31%
1년 성능:
-43.63%
1일 변동 폭
$128.82
$131.13
1주일 범위
$119.18
$131.13
52주 변동 폭
$110.03
$238.00
Biogen Inc Stock (BIIB) Company Profile
명칭
Biogen Inc
전화
(781) 464-2000
주소
225 BINNEY STREET, CAMBRIDGE, MA
BIIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
130.55 | 18.05B | 9.82B | 1.48B | 2.30B | 10.13 |
|
LLY
Lilly Eli Co
|
747.01 | 669.76B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
153.66 | 357.16B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
184.85 | 332.08B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
112.28 | 211.00B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
68.20 | 290.60B | 43.59B | 15.04B | 10.74B | 3.3766 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-04 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-11 | 개시 | Bernstein | Mkt Perform |
| 2025-01-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-11-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-31 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-02-14 | 재확인 | Needham | Buy |
| 2024-02-14 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-12-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-12-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-24 | 재확인 | UBS | Buy |
| 2023-05-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-04-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-07 | 업그레이드 | Argus | Hold → Buy |
| 2022-09-28 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | 업그레이드 | Mizuho | Neutral → Buy |
| 2022-09-28 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | 재확인 | Barclays | Equal Weight |
| 2022-02-04 | 재확인 | BofA Securities | Neutral |
| 2022-02-04 | 재확인 | Cowen | Outperform |
| 2022-02-04 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-04 | 재확인 | Needham | Buy |
| 2022-02-04 | 재확인 | Oppenheimer | Outperform |
| 2022-02-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | 재확인 | Robert W. Baird | Neutral |
| 2022-02-04 | 재확인 | Wedbush | Neutral |
| 2022-02-04 | 재확인 | Wells Fargo | Equal Weight |
| 2022-02-04 | 재확인 | Wolfe Research | Peer Perform |
| 2022-01-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-01-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-06-18 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | 재확인 | Truist | Buy |
| 2021-06-11 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | 업그레이드 | UBS | Neutral → Buy |
| 2021-06-08 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | 재확인 | Barclays | Equal Weight |
| 2021-06-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-06-08 | 재확인 | Jefferies | Buy |
| 2021-06-08 | 재확인 | Morgan Stanley | Overweight |
| 2021-06-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | 재확인 | Stifel | Buy |
| 2021-06-08 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-06-07 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-06-07 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2021-01-29 | 업그레이드 | Stifel | Hold → Buy |
| 2020-11-10 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-11-09 | 다운그레이드 | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-11-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-11-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-04 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-11-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-07-27 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-06-22 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-04-23 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-27 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
모두보기
Biogen Inc 주식(BIIB)의 최신 뉴스
Triglav Skladi D.O.O. Makes New $2.76 Million Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Tema Etfs LLC Invests $382,000 in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Cresset Asset Management LLC Reduces Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Sig Brokerage LP Invests $675,000 in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Ensign Peak Advisors Inc - MarketBeat
Rafferty Asset Management LLC Increases Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Lowers Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Ameriprise Financial Inc. Sells 1,006,463 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
ProShare Advisors LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
26,179 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Point72 Hong Kong Ltd - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Lazard Asset Management LLC - MarketBeat
Do Wall Street Analysts Like Biogen Stock? - Barchart.com
Zacks Research Has Pessimistic Outlook of Biogen Q2 Earnings - MarketBeat
Patient Capital Management LLC Has $63.30 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Man Group plc Sells 170,285 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. stock outperforms competitors on strong trading day - MSN
Baird Financial Group Inc. Trims Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Suvretta Capital Management LLC Grows Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
HSBC Adjusts Price Target on Biogen to $121 From $118, Maintains Hold Rating - marketscreener.com
Siemens Fonds Invest GmbH Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Stock Holdings Boosted by Captrust Financial Advisors - MarketBeat
Mufg Securities Americas Inc. Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
LMR Partners LLP Purchases 6,379 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
FDA approves first blood test for detecting Alzheimer's - marketscreener.com
Eisai Shares Rise as New Alzheimer’s Test Seen Helping Sales - Bloomberg.com
2,347 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by MJP Associates Inc. ADV - MarketBeat
Centiva Capital LP Sells 4,487 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Position Trimmed by Orbimed Advisors LLC - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Ethic Inc. - MarketBeat
Letko Brosseau & Associates Inc. Sells 13,330 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Graham Capital Management L.P. Buys Shares of 13,357 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
FDA Clears Alzheimer's Test: BIIB's Role in Treatment - GuruFocus
FDA clears first blood-based Alzheimer's test (BIIB:NASDAQ) - Seeking Alpha
US FDA clears first blood test for Alzheimer's detection - marketscreener.com
FDA Clears First Blood Test to Diagnose Alzheimer’s Disease - Bloomberg.com
US FDA clears first blood test to detect Alzheimer's disease - marketscreener.com
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Gotham Asset Management LLC - MarketBeat
Hudson Bay Capital Management LP Decreases Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Deutsche Bank AG - MarketBeat
Eisai Forecasts 73% Leqembi Sales Rise In FY25 As Demand Expands - insights.citeline.com
Rep. Robert Bresnahan, Jr. Sells Off Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Eisai says Leqembi is headed for 'demand expansion phase' in US - Endpoints News
Goldman Sachs maintains Biogen buy rating, $196 target By Investing.com - Investing.com UK
Dementia Drugs Market Projected To Witness Massive Growth, - openPR.com
BIIB Q1 Earnings Call: New Product Growth Outpaces Declining MS Franchise Amid Lowered Guidance - Yahoo Finance
Biogen Inc. (BIIB): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey
Eisai, Biogen to Shift Some Lecanemab Ingredient Production to US Amid Tariff Concerns - marketscreener.com
Immunomodulators Market Detailed In New Research Report 2025 | - openPR.com
Biogen Inc (BIIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.26%
0.30%
자본화:
|
볼륨(24시간):